Identification of anticancer drugs to radiosensitise BRAF-wild-type and mutant colorectal cancer. (2019)
Attributed to:
Novel strategies to improve the effectiveness of radiation and targeted therapies in lung cancer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.20892/j.issn.2095-3941.2018.0284
PubMed Identifier: 31516745
Publication URI: http://europepmc.org/abstract/MED/31516745
Type: Journal Article/Review
Volume: 16
Parent Publication: Cancer biology & medicine
Issue: 2
ISSN: 2095-3941